Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
Why Ditching Schwab U.S. Dividend Equity ETF In the AI Era Is a Mistake
10:10am, Saturday, 13'th Dec 2025
The rapid rise of artificial intelligence (AI) has transformed the stock market in recent years, powering massive gains in technology giants and growth-oriented investments. At the same time, dividend
AQR Capital Management LLC Buys 1,029,454 Shares of Merck & Co., Inc. $MRK
06:36am, Saturday, 13'th Dec 2025
AQR Capital Management LLC lifted its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 13.3% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
12:23pm, Friday, 12'th Dec 2025
One of these pharmaceutical leaders overcame a major obstacle and has a strong outlook. The other is actively pushing greater innovation to get around a rapidly approaching patent cliff.
Can MRK's New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?
11:05am, Friday, 12'th Dec 2025
Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human
Merck (MRK) Laps the Stock Market: Here's Why
06:46pm, Thursday, 11'th Dec 2025
Merck (MRK) closed at $99.01 in the latest trading session, marking a +1.42% move from the prior day.
Dividend Stocks for 2026: Where to Invest as the Market Cools
02:45pm, Wednesday, 10'th Dec 2025
As we enter the final stretch of 2025, it's clear that this has been a strong year for equities. However, with valuations across the tech sector stretched and talk of an AI-fueled bubble growing loude
2 Pharmaceutical Stocks to Buy at a Discount
10:00am, Wednesday, 10'th Dec 2025
Weight loss drugs are the big story in the pharmaceutical industry today, but other opportunities exist, too. Bristol Myers Squibb isn't focused on weight loss, has an attractive yield, and continues
Market Today: Fed Cut Looms, Nvidia's China Shift, Target's SoHo Push, OpenAI Taps Slack CEO
05:34pm, Tuesday, 09'th Dec 2025
Stock News Fed set for âhawkish cut': Goldman Sachs (GS) and other Wall Street desks expect the Federal Reserve to deliver a third straight 25 bps rate cut wh
MRK Stock Trading Above 200- & 50-Day SMA for 2 Months: Time to Buy?
12:06pm, Tuesday, 09'th Dec 2025
Merck holds bullish momentum as pipeline advances and major deals offset vaccine weakness and Keytruda risks.
FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm
11:51am, Tuesday, 09'th Dec 2025
The U.S. Food and Drug Administration granted conditional approval for a Merck Animal Health pour-on treatment for the prevention and treatment of New World Screwworm, with farmers able to receive do
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump
11:15am, Tuesday, 09'th Dec 2025
Merck spent a small fortune on the acquisition of Acceleron Pharma, and so far, it's paying off. Recent phase 2 data suggests the pharmaceutical giant could get even more bang for its buck.
1 Major Factor Behind the Healthcare Sector's Recent Surge
10:55am, Tuesday, 09'th Dec 2025
Eli Lilly's GLP-1 drug became the world's best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other companies are soaring on new drugs or the growth of existing ones.
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
08:00am, Tuesday, 09'th Dec 2025
TORONTO--(BUSINESS WIRE)--BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United
PLANEGG-MARTINSRIED, Germany and AHMEDABAD, India, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Formycon AG (FSE: FYB, “Formycon”) and Zydus Lifesciences Limited (including its subsidiaries and affiliates, �
